window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Artificial intelligence

  • Artificial Intelligence,Clinical Development,Clinical Trials,Technology and platforms

    Evinova and Bristol Myers Squibb collaborate on AI-driven clinical trial optimisation

    Evinova and Bristol Myers Squibb have entered a strategic collaboration [...]

    February 9, 2026
  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
  • Artificial Intelligence,Clinical Development,Clinical studies,Clinical Trials,Patient Centricity

    Like the ten leaping Lords, PHARMASEAL takes a leap towards smarter growth in 2026

    With the lords a-leaping, the industry is set to spring [...]

    December 30, 2025
  • Artificial Intelligence,Clinical Trials,Data Management

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    December 18, 2025
  • Neurosciences,Rare Diseases,Research & Development

    Successful treatment for ALS could deliver billions in global value

    New research commissioned by Challenge Works and conducted by the [...]

    November 13, 2025
  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Artificial Intelligence,Clinical Development,Global health,Patient Centricity,Real world evidence,Research & Development

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    August 1, 2025
  • Artificial Intelligence,Clinical Development,Global health,Medical devices,Partnerships & Funding

    Magentiq Eye secures Series A funding to advance AI-powered colonoscopy solutions

    Investment led by aMoon will support US and EU commercialisation [...]

    August 1, 2025
  • Artificial Intelligence,Oncology,Precision medicine

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    July 24, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Research & Development

    AI-powered initiative in Louisiana aims to accelerate ALS drug discovery

    A new AI-led collaboration is being launched to advance drug [...]

    July 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
  • Click Therapeutics secures $50M from Boehringer Ingelheim for schizophrenia digital therapy
    Categories: Clinical Development, Clinical Trials, Digital Health, Funding, Mental health, Neurosciences, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top